News
Market and company headlines
COOAll
Loading
11:00Oct 141 Story
10:00Oct 91 Story
10:00-12:00Oct 72 Stories
Cooper Companies Director Kurzius Buys 10,000 Shares for $539,100. What Does This Insider See in Shares?
Kurzius doubled his direct stake in the medical device company despite a 19% one-year stock decline, signaling confidence in COO's turnaround prospects.
Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?
Keel purchased 4,701 shares at $53.18 each following a 21% year-long decline, signaling confidence in the medical device company's valuation.
05:00Oct 71 Story
19:00Oct 61 Story
12:00Oct 51 Story
13:00Oct 21 Story
08:00Oct 11 Story
09:00Sep 291 Story
21:00Sep 271 Story
17:00Sep 261 Story
05:00-10:00Sep 242 Stories
COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
The Cooper Companies opens a global innovation hub in England and unveils six contact lens programs to support sustainable long-term growth.
CooperCompanies (COO) Keeps CooperSurgical and Expands Buybacks. What Did the Strategic Review Reveal?
With marginal growth across key metrics during the third quarter, The Cooper Companies Inc. (NASDAQ:COO) also finalized its strategic review process, which was initially announced in December last year. In Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision, we highlighted the company’s 1% year-over-year topline growth during the recently reported quarter, which […]
10:00-17:00Sep 232 Stories
CooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre Opening
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye CareSAN RAMON, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today reinforced its commitment to accelerate growth at CooperVision with the opening of its new global innovation hub, The Vision Centre, and the announcement of six major product advancements that have been accelerated to launch over the next several years: The build-out of the world's first & only complete family of 1-d
CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements
CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six major product advancements that have been accelerated to launch over the next several years. The announcements were made as CooperVision brings together research and development, clinical expertise, pilot manufacturing, advanced technologies, and commercial capabilities to accelerate the development and commercialization of breakthrough solutions
07:00Sep 212 Stories
Activist investor urges Cooper Companies to replace CEO, sell some assets
Citing “chronic underperformance,” Jana Partners is calling for new leadership and for the company to evaluate the sale of its fertility and medical device assets.
3 Out-of-Favor Stocks with Open Questions
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
20:00Sep 201 Story
09:00-11:00Sep 182 Stories
How Is Cooper Companies' Stock Performance Compared to Other Medical Instruments & Supplies Stocks?
As Cooper Companies has lagged behind its industry peers over the past year, Wall Street analysts maintain a cautious outlook on its prospects.
1 Value Stock with Impressive Fundamentals and 2 We Turn Down
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
07:00Sep 182 Stories
‘Crisis of Its Own Creation’: Activist JANA Blasts Cooper, Demands CEO Search
Activist firm Jana Partners calls for leadership overhaul and asset sales at Cooper Companies (COO) amid governance concerns.
Activist Calls for Cooper Cos. to Seek New CEO. What It Means for the Barron’s Stock Pick.
Cooper Cos. stock rises as activist investor Jana Partners calls for the company to search for a new CEO and sell a key business segment.
21:00-00:00Sep 102 Stories
Dow Tumbles Over 300 Points Amid Surge in Oil Prices: Fear & Greed Index Remains in ‘Fear’ Zone
U.S. stocks fell as oil topped $100 and inflation fears grew; CNN Fear & Greed dropped to 33, remaining in the Fear zone.
COO Q2 Deep Dive: Inventory Actions and Strategic Review Shape Guidance
Medical device company CooperCompanies (NASDAQ:COO) missed Wall Street’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billion. The company’s full-year revenue guidance of $4.24 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $1.15 per share was 2.7% above analysts’ consensus estimates.
14:00-21:00Sep 103 Stories
Why CooperCompanies (COO) Stock Is Trading Lower Today
Shares of medical device company CooperCompanies (NASDAQ:COO) fell 13.9% in the afternoon session after the company reported weak second-quarter results impacted by channel inventory destocking and decided to retain its CooperSurgical business.
Why is CooperCompanies Stock Down 15% Today?
Cooper won't sell its Surgical arm, and it was forced to cut forward guidance. Wall Street didn't like that.
11:00Sep 102 Stories
19:00Sep 92 Stories
A Look Back at Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including CooperCompanies (NASDAQ:COO) and its peers.
Cooper Companies Q3 Earnings Call Highlights
Cooper Companies (NASDAQ:COO) reported third-quarter fiscal 2026 revenue of $1.066 billion, up about 1% on both a reported and organic basis, as record free cash flow and earnings growth offset pressure at its CooperVision contact lens business from planned U.S. channel inventory reductions. Non-GA
17:00-19:00Sep 95 Stories
The Cooper Companies (COO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for The Cooper Companies (COO) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The Cooper Companies (COO) Beats Q3 Earnings Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of +3.60% and -2.97%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
16:00Sep 91 Story
23:00Sep 71 Story
13:00Sep 32 Stories
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
VEEV's strong Q2 results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.
Stryker Launches FDA-Cleared Apple Vision Pro Surgical App
SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.
09:00Sep 31 Story
14:00Sep 21 Story
10:00Sep 11 Story
12:00-22:00Aug 282 Stories
OSTROM CLIMATE REPORTS FISCAL Q2 2026 FINANCIAL STATEMENTS
Ostrom Climate Solutions Inc. ("Ostrom" or the "Company") (TSXV: COO) (Frankfurt: 9EAA), a leading provider of carbon project development, net-zero climate solutions, and carbon credit marketing and trading, today announced its unaudited financial results for the second quarter ended June 30, 2026.
CVRx Secures Devoted Health Coverage for Barostim Therapy
CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.
09:00Aug 281 Story
12:00Aug 216 Stories
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.
Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update
JNJ's MONARCH QUEST 3 wins FDA 510(k) clearance, adding AI-powered planning, navigation and imaging upgrades for robotic bronchoscopy.
COO vs. MMSI: Which Stock Is the Better Value Option?
COO vs. MMSI: Which Stock Is the Better Value Option?
00:00Aug 211 Story
21:00Aug 201 Story
09:00Aug 181 Story
12:00-18:00Aug 132 Stories
HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates
HeartFlow (HTFL) delivered earnings and revenue surprises of +50.00% and +12.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Citigroup Maintains Neutral on Cooper Companies, Raises Price Target to $80
Citigroup analyst Joanne Wuensch maintains Cooper Companies (NASDAQ:COO) with a Neutral and raises the price target from $76 to $80.